1. Home
  2. CPNG vs ALNY Comparison

CPNG vs ALNY Comparison

Compare CPNG & ALNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coupang Inc.

CPNG

Coupang Inc.

HOLD

Current Price

$18.10

Market Cap

32.3B

ML Signal

HOLD

Logo Alnylam Pharmaceuticals Inc.

ALNY

Alnylam Pharmaceuticals Inc.

HOLD

Current Price

$278.09

Market Cap

38.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPNG
ALNY
Founded
2010
2002
Country
United States
United States
Employees
108000
115
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
38.4B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
CPNG
ALNY
Price
$18.10
$278.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
28
Target Price
$32.00
$471.00
AVG Volume (30 Days)
25.0M
987.7K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
206.88
EPS
N/A
2.33
Revenue
$34,534,000,000.00
$1,037,418,000.00
Revenue This Year
$13.15
$52.67
Revenue Next Year
$13.75
$31.48
P/E Ratio
N/A
$119.66
Revenue Growth
14.09
22.88
52 Week Low
$14.92
$273.11
52 Week High
$34.08
$495.55

Technical Indicators

Market Signals
Indicator
CPNG
ALNY
Relative Strength Index (RSI) 56.42 38.66
Support Level $17.81 N/A
Resistance Level $20.98 $314.04
Average True Range (ATR) 0.92 10.34
MACD 0.40 -1.29
Stochastic Oscillator 67.88 13.31

Price Performance

Historical Comparison
CPNG
ALNY

About CPNG Coupang Inc.

Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.

About ALNY Alnylam Pharmaceuticals Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.

Share on Social Networks: